Related Experiment Video
Updated: Jan 24, 2026

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
Metabolic Reprogramming by MYCN Confers Dependence on the Serine-Glycine-One-Carbon Biosynthetic Pathway
Yingfeng Xia1, Bingwei Ye2, Jane Ding2
1Institute of Neural Regeneration and Repair and Department of Neurology, The First Hospital of Yichang, Three Gorges University College of Medicine, Yichang, China.
Abstract:
MYCN amplification drives the development of neuronal cancers in children and adults. Given the challenge in therapeutically targeting MYCN directly, we searched for MYCN-activated metabolic pathways as potential drug targets. Here we report that neuroblastoma cells with MYCN amplification show increased transcriptional activation of the serine-glycine-one-carbon (SGOC) biosynthetic pathway and an increased dependence on this pathway for supplying glucose-derived carbon for serine and glycine synthesis. Small molecule inhibitors that block this metabolic pathway exhibit selective cytotoxicity to MYCN-amplified cell lines and xenografts by inducing metabolic stress and autophagy. Transcriptional activation of the SGOC pathway in MYCN-amplified cells requires both MYCN and ATF4, which form a positive feedback loop, with MYCN activation of ATF4 mRNA expression and ATF4 stabilization of MYCN protein by antagonizing FBXW7-mediated MYCN ubiquitination. Collectively, these findings suggest a coupled relationship between metabolic reprogramming and increased sensitivity to metabolic stress, which could be exploited as a strategy for selective cancer therapy. SIGNIFICANCE: This study identifies a MYCN-dependent metabolic vulnerability and suggests a coupled relationship between metabolic reprogramming and increased sensitivity to metabolic stress, which could be exploited for cancer therapy.See related commentary by Rodriguez Garcia and Arsenian-Henriksson, p. 3818.
Insights
MYCN amplification in cancers creates a metabolic vulnerability by increasing reliance on the serine-glycine-one-carbon (SGOC) pathway. Inhibiting this pathway selectively kills cancer cells, offering a new therapeutic strategy.
Area of Science:
- Oncology
- Metabolic Pathways
- Cancer Biology
Background:
- MYCN amplification is a key driver of pediatric and adult neuronal cancers.
- Directly targeting MYCN presents therapeutic challenges.
- Identifying MYCN-activated metabolic pathways is crucial for novel drug development.
Purpose of the Study:
- To investigate MYCN-activated metabolic pathways as potential therapeutic targets.
- To understand the role of the serine-glycine-one-carbon (SGOC) pathway in MYCN-amplified cancers.
- To explore the therapeutic potential of targeting the SGOC pathway.
Main Methods:
- Analysis of transcriptional activation of the SGOC pathway in neuroblastoma cells.
- Assessment of cellular dependence on the SGOC pathway for biosynthesis.
- Evaluation of small molecule inhibitors targeting the SGOC pathway in cell lines and xenografts.
- Investigation of the MYCN-ATF4 feedback loop involving FBXW7.
Main Results:
- MYCN-amplified neuroblastoma cells exhibit increased SGOC pathway activation and dependence.
- Small molecule inhibitors of the SGOC pathway demonstrate selective cytotoxicity against MYCN-amplified cancers.
- Inhibition of the SGOC pathway induces metabolic stress and autophagy.
- A positive feedback loop between MYCN and ATF4 regulates SGOC pathway activation.
Conclusions:
- The SGOC pathway is a MYCN-dependent metabolic vulnerability in neuronal cancers.
- Targeting the SGOC pathway offers a selective therapeutic strategy for MYCN-amplified cancers.
- A coupled relationship exists between metabolic reprogramming and sensitivity to metabolic stress in these cancers.
More Related Videos
Related Concept Videos
Amino Acid Biosynthetic Pathways
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
cAMP-dependent Protein Kinase Pathways
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
What is Metabolism?
The Carbon Cycle

